Results 151 to 160 of about 122,325 (212)

Screening Program for Asymptomatic Hepatitis C: Uptake and Detection in the Marche Region of Italy. [PDF]

J Clin Med
Acuti Martellucci C, Rosati S, Fiore M, Martellucci M, Bizzarri S, Morettini M, Marinelli L, Imperiali G, Fani R, Brecciaroli F, Scaramuzza S, Orciani J, Filippetti F, Manzoli L.   +13 more
europepmc   +1 more source

Grounds for Accountability: Preparedness for Supply Chain Due Diligence Legislation in Canada

Regulation &Governance, EarlyView.
ABSTRACT Canada is under growing pressure to adopt mandatory supply chain due diligence legislation to hold corporations accountable for environmental and social harms embedded in global supply chains. In response, the Government of Canada is exploring policy options for stricter supply chain regulations, including legislative measures such as the ...
Emma L. Bowick, Rachel S. Friedman, Michaela L. Meil, Sophia L. Carodenuto   +3 more
wiley   +1 more source

Health Benefits, Costs, and Cost-Effectiveness of Jail-Based Hepatitis C Elimination Strategies.

JAMA Intern Med
Zhu L, Magaldi LN, Wagh IA, Ennis ER, Reitsma MB, Kuncio DE, Addish E, Varghese SR, Furukawa NW, Honeycutt AA, Chen Y, Linas BP, Salomon JA.   +12 more
europepmc   +1 more source

Prevalence and risk factors of hepatitis B and C viral infections among pregnant women attending antenatal clinic in Sekondi-Takoradi Metropolis, Western Region of Ghana. [PDF]

BMC Infect Dis
Allou F, Narkwa PW, Domfeh SA, Mutocheluh M.   +3 more
europepmc   +1 more source

Outcomes of a Routine Screening Protocol to Prevent Metamycoplasma and Ureaplasma Infection in Lung Transplant Recipients

Transplant Infectious Disease, EarlyView.
This study analyzed outcomes of an early Mollicute (Mycoplasma hominis and Ureaplasma spp.) screening protocol using BAL PCR with preemptive treatment and ammonia monitoring in lung transplant recipients. This appears to be a practical and reasonably effective approach for preventing early Mollicute infection and hyperammonemia syndrome.
Lalithaa Thirunavukarasu Murugan, Anika Sasidharan Nair, Marie M. Budev, Maureen Converse, Nabin K. Shrestha, Christine E. Koval   +5 more
wiley   +1 more source

Observational, Post-marketing Surveillance of Safety and Effectiveness of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C. [PDF]

Infect Dis Ther
Lee JW, Ahn SH, Park JG, Jeong JY, Yoon KT, Tak WY, Baek YH, Yu SJ, Song MJ, Seo YS, Jeong JY, Heo J.   +11 more
europepmc   +1 more source

Epidemiology and Outcomes of Cryptococcal Infections in Liver Transplant Recipients: A Retrospective Cohort Study at a US Academic Center

Transplant Infectious Disease, EarlyView.
Among 346 liver transplant recipients, rural residence conferred a 3.3‐fold higher risk of cryptococcal infection — a novel finding suggesting environmental exposure or healthcare access barriers may drive susceptibility. Triple immunosuppression and longer waitlist duration were additional risk factors, with very early infection carrying the worst ...
Rachel Sigler, Chloe Hanigan, Atikur Rahman, Isuru Ratnayake, Phani Akella, Lauren Carlini, Chelsea Gorsline, Erica Mackenzie, Albert Eid, Dennis Shoemaker, Ryan Taylor, Stephen Waller   +11 more
wiley   +1 more source

The China Paradox in LEAP-012 Trial. [PDF]

Liver Cancer
Kudo M.
europepmc   +1 more source

ARC in Critical Ill OLT Recipients: True Prevalence, Risk Factors, and Impact on Early Aggressive PK/PD Target Non‐Attainment of CI Beta‐Lactam Therapy for Posttransplant Gram‐Negative Infections

Transplant Infectious Disease, EarlyView.
Augmented renal clearance (ARC) represents a quite prevalent condition among critical orthotopic liver transplant recipients (23.2%). ARC is associated with different demographics and clinical features and significantly affects the attainment of aggressive beta‐lactams pharmacokinetic/pharmacodynamic targets despite the administration of standard ...
Milo Gatti, Riccardo De Paola, Matteo Rinaldi, Cristiana Laici, Antonio Siniscalchi, Pierluigi Viale, Federico Pea   +6 more
wiley   +1 more source

Policy changes in opioid agonist therapy and impacts on HIV and hepatitis C prevention in Canadian federal prisons. [PDF]

Lancet Reg Health Am
Kronfli N, Madden LM, Stoové M, Price O, Altice FL.   +4 more
europepmc   +1 more source